Use of cyproterone acetate (CPA) in the treatment of acne, hirsutism and virilism.
D000152:Acne Vulgaris / Q000188:drug therapy*; D000311:Adrenal Glands / Q000502:physiology; D000315:Adrenalectomy; D000328:Adult; D003534:Cyproterone / Q000009:adverse effects / Q000627:therapeutic use*; D004997:Ethinyl Estradiol / Q000627:therapeutic use; D005069:Evaluation Studies as Topic; D005260:Female; D006628:Hirsutism / Q000188:drug therapy* / Q000652:urine; D006801:Humans; D008598:Menstruation; D010053:Ovary / Q000502:physiology; D013739:Testosterone / Q000652:urine; D013997:Time Factors; D014770:Virilism / Q000188:drug therapy* / Q000652:urine
D013739:Testosterone; D004997:Ethinyl Estradiol; D003534:Cyproterone